Attached files
| file | filename |
|---|---|
| EX-31.1 - Pathfinder Cell Therapy, Inc. | v215984_ex31-1.htm |
| EX-2.1A - Pathfinder Cell Therapy, Inc. | v215984_ex2-1a.htm |
| EX-32.1 - Pathfinder Cell Therapy, Inc. | v215984_ex32-1.htm |
| EX-10.39 - Pathfinder Cell Therapy, Inc. | v215984_ex10-39.htm |
| EX-10.37 - Pathfinder Cell Therapy, Inc. | v215984_ex10-37.htm |
| EX-10.38 - Pathfinder Cell Therapy, Inc. | v215984_ex10-38.htm |
| EX-10.36A - Pathfinder Cell Therapy, Inc. | v215984_ex10-36a.htm |
| 10-K - Pathfinder Cell Therapy, Inc. | v215984_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-147184, 333-146493 and 333-19195) and Form S-8 (Registration Nos. 333-95127, 333-95129, 333-91386 and 333-134608) of SyntheMed, Inc. (the "Company") of our report (which included an explanatory paragraph relating to the Company's ability to continue as a going concern) dated March 24, 2011 with respect to the financial statements of SyntheMed, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2010.
/s/ EisnerAmper LLP
New York, New York
March 24, 2011